1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Neuraminidase Inhibitors Drug Market Size 2015-2025
2.1.2 Neuraminidase Inhibitors Drug Market Size CAGR by Region
2.2 Neuraminidase Inhibitors Drug Segment by Type
2.2.1 Oseltamivir
2.2.2 Oseltamivir
2.2.3 Peramivir
2.2.4 Laninamivir
2.3 Neuraminidase Inhibitors Drug Market Size by Type
2.3.1 Global Neuraminidase Inhibitors Drug Market Size Market Share by Type (2015-2020)
2.3.2 Global Neuraminidase Inhibitors Drug Market Size Growth Rate by Type (2015-2020)
2.4 Neuraminidase Inhibitors Drug Segment by Application
2.4.1 Hospital Pharmacy
2.4.2 Retail Pharmacy
2.4.3 Online Pharmacy
2.4.4 Others
2.5 Neuraminidase Inhibitors Drug Market Size by Application
2.5.1 Global Neuraminidase Inhibitors Drug Market Size Market Share by Application (2015-2020)
2.5.2 Global Neuraminidase Inhibitors Drug Market Size Growth Rate by Application (2015-2020)
3 Global Neuraminidase Inhibitors Drug by Players
3.1 Global Neuraminidase Inhibitors Drug Market Size Market Share by Players
3.1.1 Global Neuraminidase Inhibitors Drug Market Size by Players (2018-2020)
3.1.2 Global Neuraminidase Inhibitors Drug Market Size Market Share by Players (2018-2020)
3.2 Global Neuraminidase Inhibitors Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Neuraminidase Inhibitors Drug by Regions
4.1 Neuraminidase Inhibitors Drug Market Size by Regions
4.2 Americas Neuraminidase Inhibitors Drug Market Size Growth
4.3 APAC Neuraminidase Inhibitors Drug Market Size Growth
4.4 Europe Neuraminidase Inhibitors Drug Market Size Growth
4.5 Middle East & Africa Neuraminidase Inhibitors Drug Market Size Growth
5 Americas
5.1 Americas Neuraminidase Inhibitors Drug Market Size by Countries
5.2 Americas Neuraminidase Inhibitors Drug Market Size by Type
5.3 Americas Neuraminidase Inhibitors Drug Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Neuraminidase Inhibitors Drug Market Size by Regions
6.2 APAC Neuraminidase Inhibitors Drug Market Size by Type
6.3 APAC Neuraminidase Inhibitors Drug Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Neuraminidase Inhibitors Drug by Countries
7.2 Europe Neuraminidase Inhibitors Drug Market Size by Type
7.3 Europe Neuraminidase Inhibitors Drug Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Neuraminidase Inhibitors Drug by Countries
8.2 Middle East & Africa Neuraminidase Inhibitors Drug Market Size by Type
8.3 Middle East & Africa Neuraminidase Inhibitors Drug Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Neuraminidase Inhibitors Drug Market Forecast
10.1 Global Neuraminidase Inhibitors Drug Market Size Forecast (2021-2025)
10.2 Global Neuraminidase Inhibitors Drug Forecast by Regions
10.2.1 Global Neuraminidase Inhibitors Drug Forecast by Regions (2021-2025)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Neuraminidase Inhibitors Drug Forecast by Type
10.8 Global Neuraminidase Inhibitors Drug Forecast by Application
11 Key Players Analysis
11.1 Roche
11.1.1 Company Details
11.1.2 Neuraminidase Inhibitors Drug Product Offered
11.1.3 Roche Neuraminidase Inhibitors Drug Revenue, Gross Margin and Market Share (2018-2020)
11.1.4 Main Business Overview
11.1.5 Roche News
11.2 GSK
11.2.1 Company Details
11.2.2 Neuraminidase Inhibitors Drug Product Offered
11.2.3 GSK Neuraminidase Inhibitors Drug Revenue, Gross Margin and Market Share (2018-2020)
11.2.4 Main Business Overview
11.2.5 GSK News
11.3 Daiichi Sankyo
11.3.1 Company Details
11.3.2 Neuraminidase Inhibitors Drug Product Offered
11.3.3 Daiichi Sankyo Neuraminidase Inhibitors Drug Revenue, Gross Margin and Market Share (2018-2020)
11.3.4 Main Business Overview
11.3.5 Daiichi Sankyo News
11.4 Gilead Sciences
11.4.1 Company Details
11.4.2 Neuraminidase Inhibitors Drug Product Offered
11.4.3 Gilead Sciences Neuraminidase Inhibitors Drug Revenue, Gross Margin and Market Share (2018-2020)
11.4.4 Main Business Overview
11.4.5 Gilead Sciences News
…
12 Research Findings and Conclusion
...【免責事項】
https://www.globalresearch.jp/disclaimer